Details for New Drug Application (NDA): 202121
✉ Email this page to a colleague
The generic ingredient in PROGESTERONE is progesterone. There are fifty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the progesterone profile page.
Summary for 202121
Tradename: | PROGESTERONE |
Applicant: | Teva Pharms |
Ingredient: | progesterone |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202121
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Feb 29, 2012 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Feb 29, 2012 | TE: | RLD: | No |
Complete Access Available with Subscription